speb/financial-data huggingface dataset:
Financial ratios for 1057.HK — annual report dated 2023-12-31
Total revenue: 255899046.6272855
Gross profit: 49476100.85935302
Operating income: 14360044.717299577
Net income: 11936094.496483825
Capital expenditures: 8805271.303797469
Operating cash flow: 449608.3642756681
Depreciation & amortization: 12825636.199718704
Net tangible assets: 198396771.60056257
Owner earnings: 15956459.392405063
Return on net tangible assets (%): 8.042701130505602
Capex to operating income (%): 61.31785434616188
Buffett classification: The Good
Stock price: 0.2727272727272727
P/E ratio: 4.953310468143371
Shares outstanding: 216785000
Book value: 205058172.1139241
P/B ratio: 0.2883239483151872
Market cap (USD): 59123181.81818181
Debt to equity: 0.14248722053727722
Current ratio: 1.4976029157400719
Quick ratio: 1.0718606497606962
Effective tax rate (%): -1.0267302108533085
Interest coverage ratio: 14.036661071588576
COGS to revenue (%): 80.66577366682633
R&D to revenue (%): 6.496328910695268
SG&A to revenue (%): 5.2344720691617255
Free cash flow (dilution-adjusted): -8490756.210970463
Buyback yield (%): 0
Retained earnings: 50439824.70464134
Inventory turnover: 3.069096385823488
Receivables turnover: 2.535533725156023
Capitalized R&D asset: 26218576.386101104
ROCI (R&D-adjusted, %): 8.574744507325386
Rosenberg metric: 0.7560094813883915
FCF margin (%): -3.3180100992471333
Revenue growth (%): 28.466752759200137
Rule of 40 score: 25.148742659953005
Financial ratios for 1057.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.31531531531531537
Shares outstanding: 216785000
Market cap (USD): 68355630.63063064
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1057.HK — quarterly report dated 2024-12-31
Total revenue: 119986453.23424658
Gross profit: 28206537.241095893
Operating income: 12659258.275342466
Net income: 5682993.475342466
Capital expenditures: 7040378.152054794
Net tangible assets: 257903961.08356166
Owner earnings: -1357384.6767123286
Return on net tangible assets (%): -0.5263140089083517
Capex to operating income (%): 55.61446017550609
Buffett classification: The Good
Stock price: 0.37242268041237114
P/E ratio: 3.5516339726366937
Shares outstanding: 216785000
Book value: 267243978.72739726
P/B ratio: 0.30210465791467067
Market cap (USD): 80735650.77319588
Debt to equity: 0.04157581644454236
Current ratio: 1.7797128616097182
Quick ratio: 1.386737015147637
Effective tax rate (%): -30.78700140636943
Interest coverage ratio: 399.3557652982557
COGS to revenue (%): 76.49189847621466
R&D to revenue (%): 6.749578945483828
SG&A to revenue (%): -4.293490542520207
Free cash flow (dilution-adjusted): -6220274.889041096
Buyback yield (%): 0
Retained earnings: 65739071.5260274
Inventory turnover: 1.334996667243167
Receivables turnover: 0.772414207691432
Capitalized R&D asset: 8098580.3849315075
ROCI (R&D-adjusted, %): 6.44092694022622
FCF margin (%): -5.184147644482338
Rule of 40 score: -5.184147644482338
Financial ratios for 1057.HK — annual report dated 2024-12-31
Total revenue: 368968337.9821918
Gross profit: 77257999.5219178
Operating income: 31842564.586301368
Net income: 23126944.501369864
Capital expenditures: 13545202.436986303
Operating cash flow: 159778.26164383563
Depreciation & amortization: 12732173.171232877
Net tangible assets: 257903961.08356166
Owner earnings: 22313915.235616438
Return on net tangible assets (%): 8.652025018098369
Capex to operating income (%): 42.53803866920139
Buffett classification: The Good
Stock price: 0.37242268041237114
P/E ratio: 3.490977840519041
Shares outstanding: 216785000
Book value: 267243978.72739726
P/B ratio: 0.30210465791467067
Market cap (USD): 80735650.77319588
Debt to equity: 0.04157581644454236
Current ratio: 1.7797128616097182
Quick ratio: 1.386737015147637
Effective tax rate (%): -10.87440667840632
Interest coverage ratio: 56.27674144186185
COGS to revenue (%): 79.06107609546522
R&D to revenue (%): 5.929713208524336
SG&A to revenue (%): 3.401180254697067
Free cash flow (dilution-adjusted): -13714921.39452055
Buyback yield (%): 0
Retained earnings: 65739071.5260274
Inventory turnover: 4.243110547997281
Receivables turnover: 2.3752380269908286
Capitalized R&D asset: 37742538.91301965
ROCI (R&D-adjusted, %): 11.649110366598423
Rosenberg metric: 1.6711877737631002
FCF margin (%): -3.7170998111991107
Revenue growth (%): 44.1851162968929
Rule of 40 score: 40.46801648569379
Financial ratios for 1057.HK — quarterly report dated 2025-03-31
Total revenue: 98871363.8801653
Gross profit: 17950326.91460055
Operating income: 7802302.067493113
Net income: 7292880.406336089
Capital expenditures: 5430790.325068871
Net tangible assets: 265908581.28925622
Owner earnings: 1862090.081267218
Return on net tangible assets (%): 0.7002745350446703
Capex to operating income (%): 69.6049739947301
Buffett classification: The Good
Stock price: 0.4254498714652956
P/E ratio: 3.1616845898594903
Shares outstanding: 216785000
Book value: 276009277.7493113
P/B ratio: 0.3341596019441569
Market cap (USD): 92231150.38560411
Debt to equity: 0.039645629147585605
Current ratio: 1.8068483904437755
Quick ratio: 1.400022812201578
Effective tax rate (%): -2.333588433532026
Interest coverage ratio: 354.1753101324039
COGS to revenue (%): 81.84476656319131
R&D to revenue (%): 5.2513783356049215
SG&A to revenue (%): 6.223028638214748
Free cash flow (dilution-adjusted): 4653085.615702479
Buyback yield (%): 0
Retained earnings: 72814080.01790634
Inventory turnover: 1.160643805532356
Receivables turnover: 0.6736802000178261
Capitalized R&D asset: 10618158.240824219
ROCI (R&D-adjusted, %): 2.9293022238535644
Rosenberg metric: -1.2664207600604167
FCF margin (%): 4.7062015057687905
Revenue growth (%): -17.597894416346172
Rule of 40 score: -12.891692910577381
Financial ratios for 1057.HK — quarterly report dated 2025-06-30
Total revenue: 112462207.16596931
Gross profit: 20109373.133891214
Operating income: 6546885.560669456
Net income: 6854937.520223153
Capital expenditures: 6748129.792189679
Net tangible assets: 267774721.45327753
Owner earnings: 106807.72803347372
Return on net tangible assets (%): 0.03988715867345603
Capex to operating income (%): 103.07389261130821
Buffett classification: The Gruesome
Stock price: 0.6878980891719746
P/E ratio: 7.519913544578708
Shares outstanding: 216785000
Book value: 279444813.8688982
P/B ratio: 0.5336509387900435
Market cap (USD): 149125987.26114652
Debt to equity: 0.055301002034744084
Current ratio: 1.6679340803998117
Quick ratio: 1.3186566398080728
Effective tax rate (%): -4.832799560979921
Interest coverage ratio: 140.06780339171672
COGS to revenue (%): 82.11899477998486
R&D to revenue (%): 5.680579381793723
SG&A to revenue (%): 0.0970665744033642
Free cash flow (dilution-adjusted): -5890606.338912134
Buyback yield (%): 0
Retained earnings: 73022555.35704324
Inventory turnover: 1.3468491507108575
Receivables turnover: 0.6829155006867855
Capitalized R&D asset: 12539749.766164064
ROCI (R&D-adjusted, %): 2.141061813213356
Rosenberg metric: 0.41583219074564004
FCF margin (%): -5.237854108819778
Revenue growth (%): 13.745985442535696
Rule of 40 score: 8.50813133371592
Financial ratios for 1057.HK — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6670951156812339
P/E ratio: 7.292501134829415
Shares outstanding: 216785000
Market cap (USD): 144616214.6529563
Buyback yield (%): 0
Capitalized R&D asset: 5993694.414592367
Rule of 40 score: 0
Financial ratios for 1057.HK — quarterly report dated 2025-12-31
Total revenue: 155306958.74
Gross profit: 31436966.582857143
Operating income: 12740629.864285713
Net income: 4980777.565714286
Capital expenditures: 7368609.044285715
Net tangible assets: 285296547.61714286
Owner earnings: -2387831.478571429
Return on net tangible assets (%): -0.8369647296874437
Capex to operating income (%): 57.835516161891306
Buffett classification: The Good
Stock price: 0.6323907455012853
P/E ratio: 7.166905056822966
Shares outstanding: 216785000
Book value: 300381454.88571435
P/B ratio: 0.4563957778806805
Market cap (USD): 137092827.76349613
Debt to equity: 0.05554567601596372
Current ratio: 1.5647995063773035
Quick ratio: 1.263451907724267
Effective tax rate (%): -19.69196148199373
Interest coverage ratio: 266.91412529924224
COGS to revenue (%): 79.75817256489718
R&D to revenue (%): 7.344725468453367
SG&A to revenue (%): -2.2914175424042287
Free cash flow (dilution-adjusted): -1329876.69
Buyback yield (%): 0
Retained earnings: 86462182.89857142
Inventory turnover: 1.7137546687752232
Receivables turnover: 0.9358759176669404
Capitalized R&D asset: 13515076.387208607
ROCI (R&D-adjusted, %): 5.666236352309563
FCF margin (%): -0.8562891841996286
Rule of 40 score: -0.8562891841996286
Financial ratios for 1057.HK — annual report dated 2025-12-31
Total revenue: 506993144.0285714
Gross profit: 93971564.01
Operating income: 37462323.58285715
Net income: 28735297.504285716
Capital expenditures: 28886642.721428573
Operating cash flow: 33462846.882857144
Depreciation & amortization: 13708840.76
Net tangible assets: 285296547.61714286
Owner earnings: 13557495.54285714
Return on net tangible assets (%): 4.752071364372339
Capex to operating income (%): 77.10851852939302
Buffett classification: The Gruesome
Stock price: 0.6323907455012853
P/E ratio: 4.770885971967037
Shares outstanding: 216785000
Book value: 300381454.88571435
P/B ratio: 0.4563957778806805
Market cap (USD): 137092827.76349613
Debt to equity: 0.05554567601596372
Current ratio: 1.5647995063773035
Quick ratio: 1.263451907724267
Effective tax rate (%): -6.054102944924451
Interest coverage ratio: 113.28886861049934
COGS to revenue (%): 81.46492410857843
R&D to revenue (%): 6.077810817154459
SG&A to revenue (%): 2.9251561996368842
Free cash flow (dilution-adjusted): 2867155.1385714286
Buyback yield (%): 0
Retained earnings: 86462182.89857142
Inventory turnover: 5.714197996911155
Receivables turnover: 3.055128229720343
Capitalized R&D asset: 50958790.64956367
ROCI (R&D-adjusted, %): 12.58513059218144
Rosenberg metric: 0.7639172066500775
FCF margin (%): 0.5655214813732967
Revenue growth (%): 37.40830630649977
Rule of 40 score: 37.97382778787306
Financial ratios for 1717.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0192307692307694
Shares outstanding: 1775611841
Market cap (USD): 1809758222.5576925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1717.HK — annual report dated 2022-12-31
Total revenue: 1000707573.8125802
Gross profit: 435533376.1232349
Operating income: 58006161.74582799
Net income: 27795378.690629013
Capital expenditures: 71891912.70860077
Operating cash flow: -45896919.127086006
Depreciation & amortization: 32923491.65596919
Net tangible assets: 651117073.1707317
Owner earnings: -11173042.362002566
Return on net tangible assets (%): -1.7159805544022102
Capex to operating income (%): 123.93840679136386
Buffett classification: The Gruesome
Stock price: 0.4826700898587933
P/E ratio: 30.833712912814157
Shares outstanding: 1775611841
Book value: 714384595.6354301
P/B ratio: 1.1996825408693101
Market cap (USD): 857034726.8498074
Debt to equity: 0.28039897532028424
Current ratio: 1.4893159888841179
Quick ratio: 0.8708839659013711
Effective tax rate (%): 25.045666734321088
Interest coverage ratio: 20.7717201434219
COGS to revenue (%): 56.47745779879501
R&D to revenue (%): 2.5283906945432193
SG&A to revenue (%): 35.550993956522674
Free cash flow (dilution-adjusted): -136338896.02053916
Buyback yield (%): 0.5451671907097494
Retained earnings: 537656611.0397946
Inventory turnover: 1.9772029451191993
Receivables turnover: 12.551865830252598
Capitalized R&D asset: 25301797.175866496
ROCI (R&D-adjusted, %): 9.124148374892442
FCF margin (%): -13.624249439934157
Rule of 40 score: -13.624249439934157
Financial ratios for 1717.HK — annual report dated 2023-12-31
Total revenue: 945199359.7951345
Gross profit: 365243277.84891164
Operating income: 45785403.3290653
Net income: 22328681.177976955
Capital expenditures: 76353649.16773368
Operating cash flow: 28772215.10883483
Depreciation & amortization: 32095902.68886044
Net tangible assets: 639292829.7055058
Owner earnings: -21929065.300896287
Return on net tangible assets (%): -3.430206672425537
Capex to operating income (%): 166.7641728936418
Buffett classification: The Gruesome
Stock price: 0.30601792573623565
P/E ratio: 24.33502669344619
Shares outstanding: 1775611841
Book value: 736132650.4481434
P/B ratio: 0.7381401329838122
Market cap (USD): 543369052.4955187
Debt to equity: 0.42016309758790626
Current ratio: 1.2421863749948354
Quick ratio: 0.7313607769092372
Effective tax rate (%): 16.32548897180886
Interest coverage ratio: 7.022604528761366
COGS to revenue (%): 61.358069695680314
R&D to revenue (%): 1.7884702628973397
SG&A to revenue (%): 33.09922355803781
Free cash flow (dilution-adjusted): -58811139.56466069
Buyback yield (%): 0
Retained earnings: 558089244.5582587
Inventory turnover: 2.1678173110195273
Receivables turnover: 12.624404650948028
Capitalized R&D asset: 33856813.58286257
ROCI (R&D-adjusted, %): 6.1168895701922255
Rosenberg metric: -2.7780674149648066
FCF margin (%): -6.222088383281131
Revenue growth (%): -5.546896562995501
Rule of 40 score: -11.768984946276632
Financial ratios for 1717.HK — annual report dated 2024-12-31
Total revenue: 953922551.5463917
Gross profit: 400503221.6494846
Operating income: 51401030.927835055
Net income: 31854768.041237116
Capital expenditures: 40791365.97938144
Operating cash flow: 38579123.711340204
Depreciation & amortization: 36224742.26804124
Net tangible assets: 625316237.1134021
Owner earnings: 27288144.329896912
Return on net tangible assets (%): 4.363895051864479
Capex to operating income (%): 79.35904249984956
Buffett classification: The Gruesome
Stock price: 0.22551546391752578
P/E ratio: 12.57042360321692
Shares outstanding: 1775611841
Book value: 745293685.5670102
P/B ratio: 0.5372753530790033
Market cap (USD): 400427928.060567
Debt to equity: 0.3894534760133132
Current ratio: 1.2128252893184177
Quick ratio: 0.6805177327749887
Effective tax rate (%): 20.90203670223829
Interest coverage ratio: 7.723790712985555
COGS to revenue (%): 58.015121772702216
R&D to revenue (%): 1.6947252115147453
SG&A to revenue (%): 35.49228842007344
Free cash flow (dilution-adjusted): -11123711.340206185
Buyback yield (%): 0.03153842450637273
Retained earnings: 592189690.7216495
Inventory turnover: 2.2248578034670103
Receivables turnover: 10.818499091691645
Capitalized R&D asset: 35842047.39568884
ROCI (R&D-adjusted, %): 5.912686917901622
Rosenberg metric: 2.0858183001891653
FCF margin (%): -1.166102145522577
Revenue growth (%): 0.9228943778747241
Rule of 40 score: -0.243207767647853
Financial ratios for 1717.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 625316237.1134021
Buffett classification: The Gruesome
Stock price: 0.22551546391752578
Shares outstanding: 1775611841
Book value: 745293685.5670102
P/B ratio: 0.5372753530790033
Market cap (USD): 400427928.060567
Debt to equity: 0.3894534760133132
Current ratio: 1.2128252893184177
Quick ratio: 0.6805177327749887
Buyback yield (%): 0
Retained earnings: 592189690.7216495
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1717.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 664480891.7197453
Buffett classification: The Gruesome
Stock price: 0.2522292993630573
Shares outstanding: 1775611841
Market cap (USD): 447861330.59617835
Buyback yield (%): 0
Retained earnings: 608388025.477707
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1856.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.32051282051282054
Shares outstanding: 360257512
Market cap (USD): 115467151.2820513
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1856.HK — annual report dated 2022-12-31
Total revenue: 149313043.47826087
Gross profit: 81689130.43478261
Operating income: 648913.0434782609
Net income: -13117391.304347826
Capital expenditures: 3539130.4347826084
Operating cash flow: -1804347.8260869565
Depreciation & amortization: 12742391.304347826
Net tangible assets: 117219565.2173913
Owner earnings: -3914130.4347826084
Return on net tangible assets (%): -3.3391443037035664
Capex to operating income (%): 545.393634840871
Buffett classification: The Gruesome
Stock price: 0.30808729139922975
Shares outstanding: 360257512
Book value: 117219565.21739131
P/B ratio: 0.9468620777808374
Market cap (USD): 110990761.07830551
Debt to equity: 0.3770887038445132
Current ratio: 1.33019690770814
Quick ratio: 0.31906202153560403
Interest coverage ratio: 0.0529161496188619
COGS to revenue (%): 45.29002387746782
SG&A to revenue (%): 56.06327528973269
Free cash flow (dilution-adjusted): -4506521.739130435
Buyback yield (%): 0
Retained earnings: -120100000
Inventory turnover: 0.19304511336521063
Receivables turnover: 1.7629137203064644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4620135121539737
FCF margin (%): -3.0181701706365383
Rule of 40 score: -3.0181701706365383
Financial ratios for 1856.HK — annual report dated 2023-12-31
Total revenue: 196421428.57142857
Gross profit: 103645238.0952381
Operating income: -29713095.23809524
Net income: 22465476.19047619
Capital expenditures: 3829761.904761905
Operating cash flow: -11365476.19047619
Depreciation & amortization: 28857142.85714286
Net tangible assets: 95794047.61904763
Owner earnings: 47492857.14285714
Return on net tangible assets (%): 49.57808791181478
Buffett classification: The Gruesome
Stock price: 0.24327784891165172
P/E ratio: 3.9012158847885003
Shares outstanding: 360257512
Book value: 199752380.952381
P/B ratio: 0.43875658530706924
Market cap (USD): 87642672.57362355
Debt to equity: 0.33557618956803653
Current ratio: 1.2748097232500006
Quick ratio: 0.44889800962763493
Effective tax rate (%): -7.9391408797117204
Interest coverage ratio: -2.685207100591716
COGS to revenue (%): 47.233232723614194
SG&A to revenue (%): 64.62659248215087
Free cash flow (dilution-adjusted): -15464285.714285715
Buyback yield (%): 0
Retained earnings: -109072619.04761904
Inventory turnover: 0.23995024385437708
Receivables turnover: 1.3154793701415186
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.498746008730366
FCF margin (%): -7.8730135641296055
Revenue growth (%): 31.550080284865672
Rule of 40 score: 23.677066720736065
Financial ratios for 1856.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 72337777.77777778
Buffett classification: The Gruesome
Stock price: 0.2293814432989691
Shares outstanding: 360257512
Book value: 113227777.77777779
P/B ratio: 0.7298243389006437
Market cap (USD): 82636388.06185567
Debt to equity: 0.3736323045974191
Current ratio: 1.1359443350631035
Quick ratio: 0.43300128573903146
Buyback yield (%): 0
Retained earnings: -155065555.55555555
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1856.HK — annual report dated 2024-12-31
Total revenue: 110311111.1111111
Gross profit: 9582222.222222222
Operating income: -90285555.55555555
Net income: -53264444.44444444
Capital expenditures: 5574444.444444444
Operating cash flow: -30297777.777777776
Depreciation & amortization: 29958888.888888888
Net tangible assets: 72337777.77777778
Owner earnings: -28879999.999999996
Return on net tangible assets (%): -39.92381420496436
Buffett classification: The Gruesome
Stock price: 0.2293814432989691
Shares outstanding: 360257512
Book value: 113227777.77777779
P/B ratio: 0.7298243389006437
Market cap (USD): 82636388.06185567
Debt to equity: 0.3736323045974191
Current ratio: 1.1359443350631035
Quick ratio: 0.43300128573903146
Interest coverage ratio: -8.146881892921597
COGS to revenue (%): 91.31345688960516
SG&A to revenue (%): 87.19077356970185
Free cash flow (dilution-adjusted): -36380000
Buyback yield (%): 0
Retained earnings: -155065555.55555555
Inventory turnover: 0.3146433988261957
Receivables turnover: 0.7355981180306005
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.77543320290663
FCF margin (%): -32.97945205479452
Revenue growth (%): -43.83957396430577
Rule of 40 score: -76.81902601910029
Financial ratios for 1856.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.12101910828025478
Shares outstanding: 360257512
Market cap (USD): 43598042.85350318
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2102.HK — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.023166023166023165
Shares outstanding: 1000000000
Market cap (USD): 23166023.166023165
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2102.HK — annual report dated 2022-07-31
Total revenue: 50341656.050955415
Gross profit: 11086624.203821657
Operating income: 6515031.8471337585
Net income: 5740382.165605096
Capital expenditures: 847261.1464968154
Operating cash flow: 5490700.636942675
Depreciation & amortization: 5675923.566878981
Net tangible assets: 56632356.68789809
Owner earnings: 10569044.58598726
Return on net tangible assets (%): 18.662554772766125
Capex to operating income (%): 13.004712277340008
Buffett classification: The Great
Stock price: 0.020382165605095544
P/E ratio: 3.550663530247215
Shares outstanding: 1000000000
Book value: 56632356.68789809
P/B ratio: 0.35990318604295446
Market cap (USD): 20382165.605095543
Debt to equity: 0.07405232992325064
Current ratio: 5.614363237501443
Quick ratio: 3.33447144011744
Effective tax rate (%): 15.479696145550035
Interest coverage ratio: 55.832969432314414
COGS to revenue (%): 77.97723580527453
SG&A to revenue (%): 10.158610463027163
Free cash flow (dilution-adjusted): 4619363.057324841
Buyback yield (%): 0
Retained earnings: 43220764.331210196
Inventory turnover: 2.2293829536328977
Receivables turnover: 4.0821213122882405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.887095057455117
FCF margin (%): 9.176025223820924
Rule of 40 score: 9.176025223820924
Financial ratios for 2102.HK — annual report dated 2023-07-31
Total revenue: 34871410.256410256
Gross profit: 6807948.717948718
Operating income: 1016153.8461538461
Net income: 907307.6923076924
Capital expenditures: 224743.58974358975
Operating cash flow: -458076.92307692306
Depreciation & amortization: 5428974.358974359
Net tangible assets: 56620641.025641024
Owner earnings: 6111538.461538461
Return on net tangible assets (%): 10.793834811532443
Capex to operating income (%): 22.11708301791572
Buffett classification: The Great
Stock price: 0.012820512820512822
P/E ratio: 14.130281192595733
Shares outstanding: 1000000000
Book value: 56620641.025641024
P/B ratio: 0.22642825281167286
Market cap (USD): 12820512.820512822
Debt to equity: 0.02595320633727394
Current ratio: 9.426270022883294
Quick ratio: 4.983798627002288
Effective tax rate (%): 18.999656632711453
Interest coverage ratio: 9.184241019698725
COGS to revenue (%): 80.47699055504289
SG&A to revenue (%): 15.547230300334197
Free cash flow (dilution-adjusted): -525000
Buyback yield (%): 0
Retained earnings: 43123076.92307693
Inventory turnover: 1.503379074463263
Receivables turnover: 2.638570112043459
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.699301284016577
FCF margin (%): -1.5055313110071067
Revenue growth (%): -30.730506320424382
Rule of 40 score: -32.236037631431486
Financial ratios for 2102.HK — annual report dated 2024-07-31
Total revenue: 35766325.224071704
Gross profit: 7338924.455825864
Operating income: 1602816.9014084507
Net income: 907298.3354673496
Capital expenditures: 503201.0243277849
Operating cash flow: 5959411.011523688
Depreciation & amortization: 4806402.0486555705
Net tangible assets: 56815236.87580026
Owner earnings: 5210499.359795135
Return on net tangible assets (%): 9.170954212838076
Capex to operating income (%): 31.394791500239656
Buffett classification: The Good
Stock price: 0.012804097311139566
P/E ratio: 14.112334180073384
Shares outstanding: 1000000000
Book value: 56815236.87580026
P/B ratio: 0.2253637935036633
Market cap (USD): 12804097.311139567
Debt to equity: 0.012989969057551152
Current ratio: 12.635917728040889
Quick ratio: 7.091504884382343
Effective tax rate (%): 37.71097046413502
Interest coverage ratio: 11.569316081330868
COGS to revenue (%): 79.48091001843665
SG&A to revenue (%): 15.056473410063187
Free cash flow (dilution-adjusted): 5293085.787451985
Buyback yield (%): 0
Retained earnings: 43334955.185659416
Inventory turnover: 1.6505319188479926
Receivables turnover: 3.4219230439416397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6779907581721716
FCF margin (%): 14.799076377825909
Revenue growth (%): 2.5663285800061373
Rule of 40 score: 17.365404957832045
Financial ratios for 2102.HK — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 56832862.644415915
Buffett classification: The Gruesome
Stock price: 0.014120667522464698
Shares outstanding: 1000000000
Book value: 56832862.64441592
P/B ratio: 0.24845955078513215
Market cap (USD): 14120667.522464698
Debt to equity: 0.007711280967094921
Current ratio: 11.404878048780489
Quick ratio: 6.497454157023323
Buyback yield (%): 0
Retained earnings: 43317971.75866496
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2102.HK — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 56298343.949044585
Buffett classification: The Gruesome
Stock price: 0.022929936305732486
Shares outstanding: 1000000000
Book value: 56298343.94904459
P/B ratio: 0.40729326472704563
Market cap (USD): 22929936.305732485
Debt to equity: 0.005493933593095926
Current ratio: 12.220262780512384
Quick ratio: 8.39649625983489
Buyback yield (%): 0
Retained earnings: 42886751.59235669
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2102.HK — annual report dated 2025-07-31
Total revenue: 42121273.88535032
Gross profit: 8630573.248407643
Operating income: 4002675.159235669
Net income: 3587643.312101911
Capital expenditures: 30318.47133757962
Operating cash flow: 9795541.401273886
Depreciation & amortization: 4595414.012738854
Net tangible assets: 56298343.949044585
Owner earnings: 8152738.853503185
Return on net tangible assets (%): 14.481312027370109
Capex to operating income (%): 0.7574552051175966
Buffett classification: The Great
Stock price: 0.022929936305732486
P/E ratio: 6.3913645563327774
Shares outstanding: 1000000000
Book value: 56298343.94904459
P/B ratio: 0.40729326472704563
Market cap (USD): 22929936.305732485
Debt to equity: 0.005493933593095926
Current ratio: 12.220262780512384
Quick ratio: 8.39649625983489
Effective tax rate (%): 16.23390143065346
Interest coverage ratio: 176.52247191011236
COGS to revenue (%): 79.51017988701112
SG&A to revenue (%): 12.773852872506442
Free cash flow (dilution-adjusted): 9442929.936305733
Buyback yield (%): 0
Retained earnings: 42886751.59235669
Inventory turnover: 2.664808376496346
Receivables turnover: 5.62658680189225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.756288932897263
FCF margin (%): 22.418433882148
Revenue growth (%): 17.767966436209555
Rule of 40 score: 40.186400318357556
Financial ratios for 2333.HK — annual report dated 2021-12-31
Capital expenditures: 0
Operating cash flow: 5544061734.086342
Depreciation & amortization: 864849865.9968603
Buffett classification: The Gruesome
Stock price: 2.93974358974359
Shares outstanding: 2307345500
Market cap (USD): 6783004142.948718
Free cash flow (dilution-adjusted): 5377170243.130298
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2333.HK — annual report dated 2022-12-31
Total revenue: 19356746898.876434
Gross profit: 3445923131.1580462
Operating income: 830613783.966954
Net income: 1187649685.0833335
Capital expenditures: 2278637507.484195
Operating cash flow: 1768858407.9655173
Depreciation & amortization: 936801336.5675287
Net tangible assets: 6458867096.63362
Owner earnings: -154186485.83333302
Return on net tangible assets (%): -2.387206355642392
Capex to operating income (%): 274.3317714523807
Buffett classification: The Gruesome
Stock price: 1.1258023106546855
P/E ratio: 2.187189478517333
Shares outstanding: 2307345500
Book value: 9370101740.704025
P/B ratio: 0.27722376632204193
Market cap (USD): 2597614895.3786907
Debt to equity: 0.93204125587695
Current ratio: 1.1239918642835043
Quick ratio: 0.8904423459521816
Effective tax rate (%): 6.287868492461228
Interest coverage ratio: 8.07092515365666
COGS to revenue (%): 82.19781893538081
R&D to revenue (%): 4.784012384036208
SG&A to revenue (%): 4.599127020466217
Free cash flow (dilution-adjusted): -697321200.7686782
Buyback yield (%): 0
Retained earnings: 7065634071.956897
Inventory turnover: 4.949349602077118
Receivables turnover: 20.37801591537061
Capitalized R&D asset: 926029168.7887932
ROCI (R&D-adjusted, %): 10.497712247831686
FCF margin (%): -3.6024710371614885
Rule of 40 score: -3.6024710371614885
Financial ratios for 2333.HK — annual report dated 2023-12-31
Total revenue: 24082491568.111107
Gross profit: 4142675456.436005
Operating income: 1018495850.6202531
Net income: 987737373.2700422
Capital expenditures: 2282573123.9310827
Operating cash flow: 2497016741.028129
Depreciation & amortization: 1085881626.838256
Net tangible assets: 6339918082.189874
Owner earnings: -208954123.82278466
Return on net tangible assets (%): -3.295848954417558
Capex to operating income (%): 224.11216722591655
Buffett classification: The Gruesome
Stock price: 1.1638924455825865
P/E ratio: 2.7188421431379552
Shares outstanding: 2307345500
Book value: 9635553297.495075
P/B ratio: 0.27870760649490856
Market cap (USD): 2685501996.798976
Debt to equity: 0.8455276032475394
Current ratio: 1.0699119981480607
Quick ratio: 0.8296654945936647
Effective tax rate (%): 10.240728972974885
Interest coverage ratio: 7.6495944156756925
COGS to revenue (%): 82.79797817132204
R&D to revenue (%): 4.703858305766727
SG&A to revenue (%): 4.2933517516400235
Free cash flow (dilution-adjusted): 93986636.38396625
Buyback yield (%): 0
Retained earnings: 7416143578.386779
Inventory turnover: 5.324222639686332
Receivables turnover: 23.803962296108296
Capitalized R&D asset: 1753245822.9506574
ROCI (R&D-adjusted, %): 10.122686484861747
Rosenberg metric: 0.7524086160150671
FCF margin (%): 0.39026957039785243
Revenue growth (%): 24.41394049280553
Rule of 40 score: 24.80421006320338
Financial ratios for 2333.HK — quarterly report dated 2024-09-30
Total revenue: 7423292636.921541
Gross profit: 1681334711.544936
Operating income: 193635515.59771755
Net income: 477859338.6990015
Capital expenditures: 134129022.23109844
Net tangible assets: 7622295947.877318
Owner earnings: 343730316.467903
Return on net tangible assets (%): 4.509537793053367
Capex to operating income (%): 69.26881249912579
Buffett classification: The Good
Stock price: 1.7142857142857144
P/E ratio: 2.0693586523496426
Shares outstanding: 2307345500
Book value: 11032845065.134094
P/B ratio: 0.3585158139373684
Market cap (USD): 3955449428.571429
Debt to equity: 0.6563564295629873
Current ratio: 1.1300334202188362
Quick ratio: 0.8954649491358596
Effective tax rate (%): 10.678093824300687
Interest coverage ratio: 5.765362520374871
COGS to revenue (%): 77.35055326820323
R&D to revenue (%): 3.8701349566994994
SG&A to revenue (%): 10.839145946535519
Free cash flow (dilution-adjusted): 546646012.4165478
Buyback yield (%): 0
Retained earnings: 8644288332.258202
Inventory turnover: 1.6021599393168895
Receivables turnover: 7.279403207603373
Capitalized R&D asset: 287291443.2796006
ROCI (R&D-adjusted, %): 2.7195178620570286
FCF margin (%): 7.363929177433631
Rule of 40 score: 7.363929177433631
Financial ratios for 2333.HK — annual report dated 2024-12-31
Total revenue: 27344152320.38082
Gross profit: 5049382911.776712
Operating income: 1892493813.7876713
Net income: 1734248289.832877
Capital expenditures: 1537379860.658904
Depreciation & amortization: 121253172.74383561
Net tangible assets: 7424214359.939726
Owner earnings: 318121601.91780853
Return on net tangible assets (%): 4.284919406885111
Capex to operating income (%): 81.23566108688959
Buffett classification: The Gruesome
Stock price: 1.6121134020618557
P/E ratio: 2.1448500918490554
Shares outstanding: 2307345500
Book value: 10820982125.909592
P/B ratio: 0.3437490756805443
Market cap (USD): 3719702603.7371135
Debt to equity: 0.7337691375204998
Current ratio: 1.0894809067498161
Quick ratio: 0.8819261395159581
Effective tax rate (%): 11.005608208026839
Interest coverage ratio: 15.494503932244905
COGS to revenue (%): 81.53395705006669
R&D to revenue (%): 4.660916681934636
SG&A to revenue (%): 3.5565649299865476
Free cash flow (dilution-adjusted): 2177185133.612329
Buyback yield (%): 0
Retained earnings: 8409351377.663014
Inventory turnover: 6.397468388879432
Receivables turnover: 27.445514365897935
Capitalized R&D asset: 2339057990.2421994
ROCI (R&D-adjusted, %): 13.373005167901766
Rosenberg metric: 0.8004082175912998
FCF margin (%): 7.96215990937695
Revenue growth (%): 13.543701419119984
Rule of 40 score: 21.505861328496934
Financial ratios for 2333.HK — quarterly report dated 2024-12-31
Total revenue: 7857495125.916439
Gross profit: 1004310582.0917809
Operating income: 673027465.6684932
Net income: 310149185.9575342
Capital expenditures: 627136426.0575343
Net tangible assets: 7424214359.939726
Owner earnings: -316987240.10000014
Return on net tangible assets (%): -4.269640189949656
Capex to operating income (%): 93.18140165864153
Buffett classification: The Gruesome
Stock price: 1.6121134020618557
P/E ratio: 2.998317239051546
Shares outstanding: 2307345500
Book value: 10820982125.909592
P/B ratio: 0.3437490756805443
Market cap (USD): 3719702603.7371135
Debt to equity: 0.7337691375204998
Current ratio: 1.0894809067498161
Quick ratio: 0.8819261395159581
Effective tax rate (%): -0.8730263232876966
Interest coverage ratio: 24.66219364697859
COGS to revenue (%): 87.21843837001876
R&D to revenue (%): 5.379897986011586
SG&A to revenue (%): -1.799395761870627
Free cash flow (dilution-adjusted): 1170867252.4547946
Buyback yield (%): 0
Retained earnings: 8409351377.663014
Inventory turnover: 1.96651648100721
Receivables turnover: 7.886622076690847
Capitalized R&D asset: 615210489.0274694
ROCI (R&D-adjusted, %): 6.2938756874037995
Rosenberg metric: -2.3565760320757443
FCF margin (%): 14.901278762399913
Revenue growth (%): 5.849189978518249
Rule of 40 score: 20.750468740918162
Financial ratios for 2333.HK — quarterly report dated 2025-03-31
Total revenue: 5512270022.801653
Gross profit: 983308617.7438016
Operating income: 108316295.66942148
Net income: 241209189.44214875
Capital expenditures: 284608936.3636364
Net tangible assets: 8006814947.336089
Owner earnings: -43399746.92148763
Return on net tangible assets (%): -0.5420350939411552
Capex to operating income (%): 262.7572652892926
Buffett classification: The Gruesome
Stock price: 1.6053984575835476
P/E ratio: 3.8392079043289846
Shares outstanding: 2307345500
Book value: 11385929817.082645
P/B ratio: 0.3253321394318456
Market cap (USD): 3704208906.8123393
Debt to equity: 0.6757472575039607
Current ratio: 1.106012364173886
Quick ratio: 0.8209561520089224
Effective tax rate (%): 5.412045235752451
Interest coverage ratio: 4.267240208208061
COGS to revenue (%): 82.16145773562764
R&D to revenue (%): 4.7634021327773155
SG&A to revenue (%): 8.08016009884231
Free cash flow (dilution-adjusted): -1546970628.6060607
Buyback yield (%): 0
Retained earnings: 8696941881.534435
Inventory turnover: 1.0083123140999353
Receivables turnover: 5.078506877169983
Capitalized R&D asset: 640603662.8730385
ROCI (R&D-adjusted, %): 0.32974254905399064
Rosenberg metric: -0.049682307213933005
FCF margin (%): -28.06413006269604
Revenue growth (%): -29.846981328432665
Rule of 40 score: -57.911111391128706
Financial ratios for 2333.HK — quarterly report dated 2025-06-30
Total revenue: 7132072050.008368
Gross profit: 1207382309.3361228
Operating income: 608904095.9539748
Net income: 639576066.6527196
Capital expenditures: 342617752.02092046
Net tangible assets: 8396942922.415621
Owner earnings: 296958314.63179916
Return on net tangible assets (%): 3.5365050992435547
Capex to operating income (%): 56.267933537897875
Buffett classification: The Good
Stock price: 1.414012738853503
P/E ratio: 1.9550743582393117
Shares outstanding: 2307345500
Book value: 11778298678.507671
P/B ratio: 0.2770023089913427
Market cap (USD): 3262615929.9363055
Debt to equity: 0.6861602505469985
Current ratio: 1.0954780670990074
Quick ratio: 0.8271489899480836
Effective tax rate (%): 11.002251425272878
Interest coverage ratio: 17.5211273025308
COGS to revenue (%): 83.07108648271851
R&D to revenue (%): 4.562448216102284
SG&A to revenue (%): 1.3996217449713357
Free cash flow (dilution-adjusted): 2169120896.1283126
Buyback yield (%): 0
Retained earnings: 8922449103.20502
Inventory turnover: 1.2771475982246139
Receivables turnover: 5.956723398128529
Capitalized R&D asset: 640819381.1331692
ROCI (R&D-adjusted, %): 4.1682187125785175
Rosenberg metric: 0.8533813328535084
FCF margin (%): 30.41361445760728
Revenue growth (%): 29.385389694379267
Rule of 40 score: 59.79900415198655
Financial ratios for 2471.T — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.136731107205623
Shares outstanding: 78103645
Market cap (USD): 791715647.8576449
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2471.T — annual report dated 2022-11-30
Total revenue: 13283840.276776703
Gross profit: 12008072.653884964
Operating income: -627072.2214213636
Net income: 2724520.68617558
Capital expenditures: 19914948.82514055
Operating cash flow: 20628513.76675796
Depreciation & amortization: 6256306.760847628
Net tangible assets: 12188265.82096007
Owner earnings: -10934121.378117342
Return on net tangible assets (%): -89.71023063276168
Buffett classification: The Gruesome
Stock price: 6.1750756811301715
P/E ratio: 177.02046502870368
Shares outstanding: 78103645
Book value: 12368458.988035172
P/B ratio: 38.99401852030886
Market cap (USD): 482295918.8471241
Debt to equity: 2.7022144522144522
Current ratio: 1.2400180464696595
Quick ratio: 1.2188134446198964
Effective tax rate (%): 3.571428571428572
Interest coverage ratio: -3.346153846153846
COGS to revenue (%): 9.60390667390125
SG&A to revenue (%): 95.11665762344005
Free cash flow (dilution-adjusted): 627072.2214213636
Buyback yield (%): 0
Retained earnings: 8087069.33833069
Inventory turnover: 1.8829787234042554
Receivables turnover: 4.473300970873786
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.2499066118789695
FCF margin (%): 4.720564297341292
Rule of 40 score: 4.720564297341292
Financial ratios for 2471.T — annual report dated 2023-11-30
Total revenue: 175353645.26659414
Gross profit: 60575353.6452666
Operating income: 18886017.41022851
Net income: 11765505.984766051
Capital expenditures: 28366430.903155606
Operating cash flow: 27863166.485310122
Depreciation & amortization: 17770674.646354735
Net tangible assets: 56957290.53318825
Owner earnings: 1169749.7279651798
Return on net tangible assets (%): 2.0537313432835824
Capex to operating income (%): 150.19805545552757
Buffett classification: The Gruesome
Stock price: 2.526387377584331
P/E ratio: 16.77106476566474
Shares outstanding: 78103645
Book value: 57773394.99455932
P/B ratio: 3.4154140134902877
Market cap (USD): 197320062.87132755
Debt to equity: 2.33372572101236
Current ratio: 0.7778384279475982
Quick ratio: 0.7561135371179039
Effective tax rate (%): 34.80558701396754
Interest coverage ratio: 21.866141732283463
COGS to revenue (%): 65.45144275519702
SG&A to revenue (%): 24.13512255662426
Free cash flow (dilution-adjusted): -829706.2023939064
Buyback yield (%): 0
Retained earnings: 55148258.97714908
Inventory turnover: 84.80402010050251
Receivables turnover: 8.092906465787822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.466204219827407
FCF margin (%): -0.47316165063605337
Revenue growth (%): 1220.0523464073399
Rule of 40 score: 1219.5791847567039
Financial ratios for 2471.T — annual report dated 2024-11-30
Total revenue: 169041476.48342925
Gross profit: 62538863.53112391
Operating income: 18409737.381755643
Net income: 13885030.098564532
Capital expenditures: 21591585.632069856
Operating cash flow: 33545015.54541245
Depreciation & amortization: 22451544.61864127
Net tangible assets: 64318317.12641398
Owner earnings: 14744989.085135944
Return on net tangible assets (%): 22.92502314100587
Capex to operating income (%): 117.28350700682715
Buffett classification: The Gruesome
Stock price: 2.037441291261494
P/E ratio: 11.460658723201526
Shares outstanding: 78103645
Book value: 64999669.246543616
P/B ratio: 2.44819078567067
Market cap (USD): 159131591.3210293
Debt to equity: 2.4427030327702024
Current ratio: 0.7614296868222434
Quick ratio: 0.7374859026633123
Effective tax rate (%): 18.256130790190735
Interest coverage ratio: 13.004672897196262
COGS to revenue (%): 63.00383501604446
SG&A to revenue (%): 26.25420677780387
Free cash flow (dilution-adjusted): 11477144.936164584
Buyback yield (%): 0
Retained earnings: 62300721.0425349
Inventory turnover: 58.333333333333336
Receivables turnover: 6.051148472649775
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.87334586866286
FCF margin (%): 6.789543711356344
Revenue growth (%): -3.599679250219381
Rule of 40 score: 3.189864461136963
Financial ratios for 2471.T — quarterly report dated 2025-02-28
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.9566695553629758
Shares outstanding: 78103645
Market cap (USD): 152823024.3343777
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2471.T — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 63089442.20336625
Buffett classification: The Gruesome
Stock price: 2.390596745027125
Shares outstanding: 78103645
Market cap (USD): 186714319.51175407
Quick ratio: -0.02358173883853642
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2471.T — annual report dated 2025-11-30
Total revenue: 166553621.7046327
Gross profit: 62292039.92833376
Operating income: 15478628.103404146
Net income: 9239825.953416944
Capital expenditures: 12183260.813923726
Operating cash flow: 35961095.46966983
Depreciation & amortization: 24110570.77041208
Net tangible assets: 64710775.53109803
Owner earnings: 21167135.9099053
Return on net tangible assets (%): 32.710372787501235
Capex to operating income (%): 78.71021083092187
Buffett classification: The Gruesome
Stock price: 1.7788584591758383
P/E ratio: 15.036574314404433
Shares outstanding: 78103645
Book value: 65293063.73176351
P/B ratio: 2.1278727273618183
Market cap (USD): 138935329.60071668
Debt to equity: 2.3976871814974516
Current ratio: 0.6740113458850613
Quick ratio: 0.6331497163528735
Effective tax rate (%): 31.935939707960433
Interest coverage ratio: 8.144781144781144
COGS to revenue (%): 62.59940835222253
SG&A to revenue (%): 27.861231703100387
Free cash flow (dilution-adjusted): 23624264.14128487
Buyback yield (%): 1.261927674171118
Retained earnings: 64448425.90222677
Inventory turnover: 32.78470824949699
Receivables turnover: 6.87325059413784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.198888286334057
FCF margin (%): 14.184179184755466
Revenue growth (%): -1.4717422200464703
Rule of 40 score: 12.712436964708996
Financial ratios for 2471.T — quarterly report dated 2025-11-30
Capital expenditures: 0
Net tangible assets: 64710775.53109803
Buffett classification: The Gruesome
Stock price: 1.7788584591758383
Shares outstanding: 78103645
Book value: 65293063.73176351
P/B ratio: 2.1278727273618183
Market cap (USD): 138935329.60071668
Debt to equity: 2.3976871814974516
Current ratio: 0.6740113458850613
Quick ratio: 0.6331497163528735
Buyback yield (%): 0
Retained earnings: 64448425.90222677
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2471.T — quarterly report dated 2026-02-28
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.6874117798023867
Shares outstanding: 78103645
Market cap (USD): 131793010.61850378
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3197.T — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.863853849499783
Shares outstanding: 227393580
Market cap (USD): 2925157779.434537
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3197.T — annual report dated 2022-12-31
Total revenue: 2284870598.8564553
Gross profit: 1556650616.9124286
Operating income: -41950045.1399338
Net income: -47931086.36774
Capital expenditures: 100173036.41287994
Operating cash flow: 343936202.22690344
Depreciation & amortization: 356590430.3340355
Net tangible assets: 59035510.08125189
Owner earnings: 208486307.5534156
Buffett classification: The Gruesome
Stock price: 11.242476677700873
Shares outstanding: 227393580
Book value: 1186488113.1507673
P/B ratio: 2.1546503428678316
Market cap (USD): 2556467019.8089075
Debt to equity: 0.6782851852791236
Current ratio: 0.26596995759991354
Quick ratio: 0.21934257617076997
Interest coverage ratio: -2.18752451941938
COGS to revenue (%): 31.8713883538302
SG&A to revenue (%): 70.97907508931365
Free cash flow (dilution-adjusted): 225157989.7682817
Buyback yield (%): 0
Retained earnings: 424503460.72825766
Inventory turnover: 13.196319018404909
Receivables turnover: 17.92510181195774
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.084789931990085
FCF margin (%): 9.8542994023806
Rule of 40 score: 9.8542994023806
Financial ratios for 3197.T — annual report dated 2023-12-31
Total revenue: 2508880718.376582
Gross profit: 1696139432.9350207
Operating income: 82641589.47889414
Net income: 33804709.04334299
Capital expenditures: 90284946.61670084
Operating cash flow: 500014141.27130026
Depreciation & amortization: 343979353.74390155
Net tangible assets: 109601923.21289684
Owner earnings: 287499116.17054373
Return on net tangible assets (%): 262.31210889620024
Capex to operating income (%): 109.24880219028064
Buffett classification: The Gruesome
Stock price: 14.337340026868414
P/E ratio: 96.44274921008157
Shares outstanding: 227393580
Book value: 1147493459.6620238
P/B ratio: 2.8411657155302232
Market cap (USD): 3260219076.3869047
Debt to equity: 0.6119354242405569
Current ratio: 0.46609550920603643
Quick ratio: 0.4120180288680864
Effective tax rate (%): 44.98906915199632
Interest coverage ratio: 4.705314009661835
COGS to revenue (%): 32.39457657307281
SG&A to revenue (%): 62.97786833732114
Free cash flow (dilution-adjusted): 395036413.77359825
Buyback yield (%): 0
Retained earnings: 536590539.4895001
Inventory turnover: 19.39362240593892
Receivables turnover: 20.825859842704546
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6929960093651943
FCF margin (%): 15.74552392547438
Revenue growth (%): 9.804061535574078
Rule of 40 score: 25.54958546104846
Financial ratios for 3197.T — annual report dated 2024-12-31
Total revenue: 2555130900.057328
Gross profit: 1720969488.5024524
Operating income: 154054398.36932287
Net income: 88954710.49111408
Capital expenditures: 86464105.99401236
Operating cash flow: 432658131.09115225
Depreciation & amortization: 304649977.7055863
Net tangible assets: 1815402.2549206954
Owner earnings: 307140582.20268804
Return on net tangible assets (%): 16918.59649122807
Capex to operating income (%): 56.12569774653712
Buffett classification: The Good
Stock price: 15.361436625071262
P/E ratio: 39.26820793224891
Shares outstanding: 227393580
Book value: 1104350595.5793364
P/B ratio: 3.163028192406248
Market cap (USD): 3493092068.118072
Debt to equity: 0.61331126133401
Current ratio: 0.4178578721666326
Quick ratio: 0.35172894969709345
Effective tax rate (%): 34.955752212389385
Interest coverage ratio: 9.348666408967915
COGS to revenue (%): 32.64652357091218
SG&A to revenue (%): 61.3080547453444
Free cash flow (dilution-adjusted): 324071596.91700107
Buyback yield (%): 0
Retained earnings: 572399515.892732
Inventory turnover: 16.84958826556871
Receivables turnover: 19.277681660899653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.844720918780317
FCF margin (%): 12.683170044623937
Revenue growth (%): 1.8434587719528222
Rule of 40 score: 14.526628816576759
Financial ratios for 3197.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.8404625050127
Shares outstanding: 227393580
Market cap (USD): 4511593797.870605
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0